News and Trends 19 Jun 2020 Cancer Drug Inspired by Sea Animal Gets FDA Green Light The Spanish company PharmaMar’s stock price has shot up by 30% as its cancer drug lurbinectedin was given accelerated approval for the second-line treatment of metastatic small cell lung cancer in the US this week. Lurbinectedin will be marketed under the brand name Zepzelca and will be made commercially available in the US in early […] June 19, 2020 - 3 minutesmins - By Manuela Callari Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jun 2020 What Did European Oncology Players Offer at ASCO 2020? Despite widespread clinical trial delays caused by the coronavirus pandemic, many oncology biotechs have been able to continue their fight against cancer. With advances in CAR T-cell therapies, cancer vaccines, RNA drugs, and more, European companies held a strong presence at the American Society of Clinical Oncology (ASCO) this year. The huge ASCO conference has […] June 3, 2020 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Apr 2020 Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop a new generation of drugs that target DNA repair in cancer cells. The drugs will block a DNA repair process called break-induced replication, which was discovered by the company’s scientific founder Thanos Halazonetis. This process is used by cancer cells […] April 24, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial of a therapeutic vaccine that could offer a new way to treat advanced prostate cancer. In the open-label trial, the University of Oxford spin-off enrolled 23 patients with advanced castration-resistant prostate cancer. The patients received the company’s viral vector vaccine […] March 24, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 18 Mar 2020 OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […] March 18, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Startup Scout 13 Mar 2020 This Startup Hits Hidden Proteins to Make Cancer Immunotherapies With one foot in Belgium and another in the US, Orionis Biosciences combines US and European talent to develop cancer immunotherapies targeting difficult protein targets. Mission: To fight cancer with two technologies. The first is modifying immune proteins called cytokines to trigger the body to produce specific immune cells against a tumor. The second is […] March 13, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2020 Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […] March 4, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2020 Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B UK biotech Bicycle Therapeutics will collaborate with Genentech, now part of the Roche Group, to develop novel cancer immunotherapies and take them to market. Genentech will pay €28M upfront to Bicycle, but if discovery, regulatory and commercial milestones are met then the deal could be worth up to €1.6B for the Cambridge-based company. Bicycle’s technology […] February 26, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Feb 2020 Meet 20 European Immuno-Oncology Companies that are Fighting Cancer With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology has become a buzzword in biotech, with more and more companies starting up in Europe and elsewhere. With so many players involved, it can be hard to know who is doing what. Here are 20 European companies we think stand […] February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 18 Feb 2020 OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […] February 18, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 12 Feb 2020 Boosting Cancer Research by Unlocking Genomic Data More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although there is a lot of data out there, much of it is inaccessible. With a background in computer science and bioinformatics, Fiona Nielsen, co-founder and CEO of Repositive, decided to overcome this bottleneck and open […] February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2020 Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools Swiss company Lunaphore Technologies has raised €21.5M (CHF 23M) in Series C funding to expand the automation of cancer research and tissue diagnostics in Europe and the US. The oversubscribed funding round was completed in mid-January and was led by Japan-based PHC Holdings Corporation, with further contributions from existing investors including Redalpine Venture Partners, OCCIDENT […] February 6, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email